SANA BIOTECHNOLOGY INC (SANA)
US7995661045 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -305.81M | -283.25M | -269.48M | -355.93M | -285.31M | |||
| Depreciation Amortization | 22.96M | 24.56M | 15.63M | 11.07M | 5.92M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | 4.79M | 18.61M | 7.54M | 9.80M | 6.16M | |||
| Other non cash items | 50.11M | -13.49M | -43.74M | 84.00M | 135.25M | |||
| OPERATING CASH FLOW | -227.95M | -253.58M | -290.05M | -251.05M | -137.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -47.04M | -20.03M | -20.88M | -29.86M | -23.87M | |||
| Other Investing Activity | 32.71M | 192.04M | 231.44M | -215.94M | -228.69M | |||
| INVESTING CASH FLOW | -14.32M | 172.01M | 210.56M | -245.80M | -252.56M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 193.02M | 31.65M | 4.91M | 631.75M | 435.69M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 200.82M | 31.65M | 4.91M | 631.75M | 435.69M | |||
| CHANGE IN CASH | -41.45M | -49.92M | -74.58M | 134.90M | 45.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -227.95M | -253.58M | -290.05M | -251.05M | -137.98M | |||
| Capital Expenditure | -47.04M | -20.03M | -20.88M | -29.86M | -23.87M | |||
| FREE CASH FLOW | -274.99M | -273.61M | -310.93M | -280.91M | -161.85M | |||
All data in USD